The UGT2B10D67Y Gene Polymorphism as a Marker for Response to Olanzapine Treatment and Prevention of Side Effects

<p>We have discovered the enzymes responsible for <span class="caps">OLZ</span> gucuronidation. Since glucuronidation is a major mode of <span class="caps">OLZ</span> elimination from the body, a polymorphism in the genes responsible for glucuronidation could significantly impact <span class="cap...

Up-Conversion Luminescent Coatings/Materials for Antimicrobial Applications

This invention describes a coating system adapted to absorb impinging wavelengths of radiation such that embedded particles are stimulated and emit ultraviolet wavelength energies sufficient for use in antimicrobial applications.

Facile, High Yield Synthesis and Purification of CdS Quantum Dots from Optimized Strains of S. maltophilia

Quantum Dot Synthesis Description: A major barrier to the utilization of quantum dots (QDs) in commercial applications is the high cost associated with conventional chemical synthesis as well as the use of high temperatures and toxic solvents, thereby requiring specialized, exp...

Determining Oocyte Quality

<p>Background</p> <p>Globally, there are greater than 4 million babies born per year; over 250,000 of these are from assisted reproduction. In the US, the number of <span class="caps">ART</span> (Assisted Reproduction Technology) cycles has increased from approximately 83,000 in 1999 to 148,055....

Inhibition of angiogenesis by high molecular weight kininogen and peptide analogs thereof

The compounds of the present invention are in the form of peptides which possess anti-angiogenic activity. In all embodiments, the peptide may optionally comprise an amino-terminal and/or carboxy-terminal protecting group.

Biomarker for HIV-1 Infection

<p>This invention relates to measurements of monocyte CD 163, a monocyte/macrophage-specific scavenger receptor for hemoglobin-haptoglobin complex, mean fluorescence intensity and frequency measurements in blood which is an important surrogate marker for clinical management of <span class="caps">...

Fluorochemical Liquid Augmented Cryosurgery

<p>Perfluorochemical cryosurgery represents a fundamental platform technology that can be used for a wide variety of clinical cryosurgical applications. Perfluorochemical (<span class="caps">PFC</span>) liquids are biologically non-toxic substances that, in varying forms, are currently used as ar...

Obesity Controlling Method

<p>The invention is a method of treating obesity in which gastric emptying is slowed by narrowing the pyloric sphincter or pylorus, thus narrowing the lumen of the pylorus through which food must pass from the stomach into the small intestine. The invention comprises narrowing of the pyloric sphi...

Inhibition of angiogenesis by antibodies against high molecular weight kininogen domain 5

<p>The present invention is based upon the discovery that antibodies which bind to HK domain 5 inhibit endothelial cell proliferation, tube formation and neovascularization. This activity confers upon such antibodies the ability to inhibit cytokine-driven angiogenesis in vivo. According to the as...

Process for Synthesis of Silane Dipeptide Analogs

<p>The present invention relates to the unexpected discovery that a substituted 1,2-oxasilolane may be efficiently converted to the dilithium salt of a substituted 3-hydroxypropylsilanol using lithium metal, which reductively cleaves the Si-O bond in high yields. The substituted 1,2-oxasilolane ...